New compound ZTA-26 could be a game-changer in lipid metabolism regulation

Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders.

Grünenthal acquires Valinor Pharma

The acquisition aligns with Grünenthal’s strategy to expand its product portfolio. Credit: fizkes / Shutterstock. Grünenthal has announced the acquisition of US-based Valinor Pharma, along

July 23, 2024

CRISPR-based Casgevy is made accessible in England following NICE guidance – Pharmaceutical Technology

The CRISPR/Cas9 gene-editing therapy Casgevy offers a one-time curative option for beta-thalassemia patients. Image: Shutterstock/Perception7 Following positive guidance issued by the National Institute for Health

August 8, 2024

NICE recommends Lilly’s tirzepatide for type 2 diabetes treatment

Tirzepatide is intended for use in adult patients with inadequately controlled type 2 diabetes. Credit: joshimerbin / Shutterstock.com. The UK National Institute for Health and

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.